Colorectal dysplasia and carcinoma in patients with ulcerative colitis and primary sclerosing cholangitis

Scandinavian Journal of Gastroenterology

Volumn 32, Issue 7, 1997, Pages 706-711

  Leidenius, M H K ^a   Farkkila M A ^b   Karkkainen P ^b   Taskinen, E I ^b   Kellokumpu, I H ^b   Hockerstedt K A V ^b  

^a NONE   (Finland)

^b NONE

Author keywords

Colorectal carcinoma; Dysplasia; Primary sclerosing cholangitis; ulcerative colitis

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; COLORECTAL CARCINOMA; COLORECTAL DISEASE; CONTROLLED STUDY; DYSPLASIA; FEMALE; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL; SCLEROSING CHOLANGITIS; ULCERATIVE COLITIS;

EID: 0030751306     PISSN: 00365521     EISSN: None     Source Type: Journal    
DOI: 10.3109/00365529708996522     Document Type: Article

References (36)

1. Langholz E, Munkholm P, Davidsen M, Binder V. Colorectal cancer risk and mortality in patients with ulcerative colitis. Gastroenterology 1992;103:1444-51.
2. Ekbom A, Helmick C, Zack M, Adami H-O. Ulcerative colitis and colorectal cancer. A population based study. N Engl J Med 1990;323:1228-33.
3. Edwards F, Truelove S. The course and prognosis of ulcerative colitis. Gut 1964;5:1-22.
4. Devroede GJ, Taylor WF, Sauer WG, Jackman RJ, Stickler GB. Cancer risk and life expectancy of children with ulcerative colitis. N Engl J Med 1971;285:17-21.
5. Greenstein AJ, Sachar DB, Smith H, Pucillo A, Papatestas AE, Kreel I, et al. Cancer in universal and left-sided ulcerative colitis: factors determining risk. Gastroenterology 1979;77:290-4.
6. Lennard-Jones JE. Cancer risk in ulcerative colitis: surveillance or surgery. Br J Surg 1985;72 Suppl:84-6.
7. Lashner B, Silverstein M, Hanauer S. Hazard rates for dysplasia and cancer in extensive ulcerative colitis. Results from a surveillance program. Dig Dis Sci 1989;10:1536-41.
8. Aadland H, Schrumpf E, Fausa O, Elgjo K, Heilo A, Aakhus T, et al. Primary sclerosing cholangitis: a long-term follow-up study. Scand J Gastroenterol 1987;22:655-64.
9. Wiesner RH, LaRusso NF. Clinicopathologic features of the syndrome of primary sclerosing cholangitis. Gastroenterology 1980;79:2000-6.
10. Shepherd HA, Selby WS, Chapman RGW, Nolan D, Barbatis C, McGee JO'D, et al. Ulcerative colitis and persistent liver dysfunction. Q J Med 1983;208:503-13.
11. Olsson R, Danielsson Å, Järnerot G, Lindström E, Lööf L, Rolny P, et al. Prevalence of primary sclerosing cholangitis in patients with ulcerative colitis. Gastroenterology 1991;100:1319.
12. Wee A, Ludwig J, Coffey R, LaRusso NF, Wiesner RH. Hepatobiliary carcinoma associated with primary sclerosing cholangitis and chronic ulcerative colitis. Human Pathol 1985; 16:719-26.
13. Rosen CB, Nagorney DM, Wiesner RH, Coffey RJ, LaRusso NF. Cholangiocarcinoma complicating primary sclerosing cholangitis. Ann Surg 1991;213:21-5.
14. Farrant MJ, Hayllar KM, Wilkinson ML, Karani J, Portmann BC, Westaby D, et al. Natural history and prognostic variables in primary sclerosing cholangitis. Gastroenterology 1991;100: 1710-7.
15. Bansal P, Sonnenberg A. Sclerosing cholangitis as a risk factor for gastrointestinal cancer. Gastroenterology 1995;4:A405.
16. Higashi H, Yanaga K, Marsh J, Tzakis A, Kakizoe S, Starzl T. Development of colon cancer after liver transplantation for primary sclerosing cholangitis associated with ulcerative colitis. Hepatology 1990;11:477-80.
17. Bleday R, Lee E, Jessurun J, Heine J, Wong W. Increased risk of early colorectal neoplasms after hepatic transplant in patients with inflammatory bowel disease. Dis Colon Rectum 1993;36: 908-12.
18. Broomé U, Lindberg G, Löfberg R. Primary sclerosing cholangitis in ulcerative colitis - a risk factor for development of dysplasia and DNA ancuploidy? Gastroenterology 1992; 102:1877-80.
19. D'Haens G, Lahaer B, Hanauer S. Pericholangitis and sclerosing cholangitis are risk factors for dysplasia and cancer in ulcerative colitis. Am J Gastroenterol 1993;88:1174-8.
20. Brentnall T, Haggit R, Rabinovitch P, Kimmey M, Bronner M, Levine O, et al. Risk and natural history of colonic neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis. Gastroenterology 1996;110:331-8.
21. Broomé U, Löfberg, Veress B, Eriksson LS. Primary sclerosing cholangitis and ulcerative colitis: evidence for increased neoplastic potential, Hepatology 1995;5:1404-8.
22. Gurbuz A, Giardiello F, Bayless T. Colorectal neoplasia in patients with ulcerative colitis and primary sclerosing cholangitis. Dis Colon Rectum 1995;38:37-41.
23. Loftus Jr E, Sandborn W, Tremaine W, Mahoney D, Zinsmeister A, Offord K, et al. Risk of colorectal neoplasia in patients with primary sclerosing cholangitis. Gastroenterology 1996;110:432-40.
24. de Dombal FT, Watts J, Watkinson G, Goligher JC. Local complications of ulcerative colitis: stricture, pseudopolyposis and carcinoma of colon and rectum. Br Med J 1966;1:1442-7.
25. Kewenter J, Ahlman H, Hulten L. Cancer risk in extensive ulcerative colitis. Ann Surg 1978;188:824-8.
26. Truelove SC. Natural history of ulcerative colitis. In: Allan RN, Keighlcy MRB, Alexander-Williams J, Hawkins C, editors. Inflammatory bowel disease. Birmingham: Churchill Livingstone; 1984. p. 94-100.
27. Welin S, Welin G. The double contrast examination of the colon. Experiences with the Welin modification. Tubingen: Thieme 1976. p. 82-97.
28. Nixon JB, Riddel RH. Histopathology of ulcerative colitis. In: Allan RN, Keighley MRB, Alexander-Williams J, Hawkins C, editors. Inflammatory bowel disease. Birmingham: Churchill Livingstone; 1983. p. 194-209.
29. Chapman RWG, Arborgh BÅM, Rhodes JM, Summerfield JA, Dick R, Scheuer PJ, et al. Primary sclerosing cholangitis: a review of its clinical features, cholangiography, and hepatic histology. Gut 1980;21:870-7.
30. Riddel RH, Goldman H, Ransohoff DF, Appelman HD, Fenoglio CM, Haggit RC, et al. Dysplasia in inflammatory bowel disease: standardized classification with provisional clinical applications. Human Pathol 1983;14:931-68.
31. Ahnen DJ. Controlled clinical trials: the controls are the key. Gastroenterology 1996;100:628-30.
32. Leidenius M, Kellokumpu I, Husa A, Riihelä M, Sipponen P. Dysplasia and cancer in long-standing ulcerative colitis - an endoscopic and histologic surveillance programme. Gut 1991; 32:1521-5.
33. Broomé U, Löfberg R, Lundqvist K, Veress B. Subclinical time span of inflammatory bowel disease in patients with primary sclerosing cholangitis. Dis Colon Rectum 1995;12:1301-5.
34. Hill MJ, Melville DM, Lennard-Jones JE, Ritchie JK. Faecal bile acids, dysplasia and carcinoma in ulcerative colitis. Lancet 1987;2:185-7.
35. Nagengast FM, Grubben MJAL, Munster IP. Role of bile acids in colorectal carcinogenesis. Eur J Cancer 1995;7/8:1067-70.
36. Kyllönen L, Pukkala E, Eklund B. Cancer incidence in a kidney transplanted population. Transpl Int 1994;7 Suppl 1:S350-2.